399 related articles for article (PubMed ID: 19841897)
1. The effects of vasopressin on acute kidney injury in septic shock.
Gordon AC; Russell JA; Walley KR; Singer J; Ayers D; Storms MM; Holmes CL; Hébert PC; Cooper DJ; Mehta S; Granton JT; Cook DJ; Presneill JJ
Intensive Care Med; 2010 Jan; 36(1):83-91. PubMed ID: 19841897
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
3. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of short-term vasopressin infusion during severe septic shock.
Patel BM; Chittock DR; Russell JA; Walley KR
Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
[TBL] [Abstract][Full Text] [Related]
5. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
6. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
[TBL] [Abstract][Full Text] [Related]
7. Selepressin, a novel selective vasopressin V
Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
[TBL] [Abstract][Full Text] [Related]
8. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
Russell JA; Lee T; Singer J; Boyd JH; Walley KR;
Crit Care Med; 2017 Jun; 45(6):940-948. PubMed ID: 28333757
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial.
Hajjar LA; Zambolim C; Belletti A; de Almeida JP; Gordon AC; Oliveira G; Park CHL; Fukushima JT; Rizk SI; Szeles TF; Dos Santos Neto NC; Filho RK; Galas FRBG; Landoni G
Crit Care Med; 2019 Dec; 47(12):1743-1750. PubMed ID: 31609774
[TBL] [Abstract][Full Text] [Related]
10. The REPERFUSE study protocol: The effects of vasopressor therapy on renal perfusion in patients with septic shock-A mechanistically focused randomised control trial.
McDonald R; Watchorn J; Mehta R; Ostermann M; Hutchings S
PLoS One; 2024; 19(6):e0304227. PubMed ID: 38870103
[TBL] [Abstract][Full Text] [Related]
11. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
[TBL] [Abstract][Full Text] [Related]
12. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
[TBL] [Abstract][Full Text] [Related]
13. Low-dose vasopressin in the treatment of vasodilatory septic shock.
Malay MB; Ashton RC; Landry DW; Townsend RN
J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
[TBL] [Abstract][Full Text] [Related]
14. Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH).
Gordon AC; Mason AJ; Perkins GD; Ashby D; Brett SJ
BMJ Open; 2014 Jul; 4(7):e005866. PubMed ID: 24993769
[TBL] [Abstract][Full Text] [Related]
15. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial.
Liu ZM; Chen J; Kou Q; Lin Q; Huang X; Tang Z; Kang Y; Li K; Zhou L; Song Q; Sun T; Zhao L; Wang X; He X; Wang C; Wu B; Lin J; Yuan S; Gu Q; Qian K; Shi X; Feng Y; Lin A; He X; ; Guan XD
Intensive Care Med; 2018 Nov; 44(11):1816-1825. PubMed ID: 29971593
[TBL] [Abstract][Full Text] [Related]
16. Bench-to-bedside review: Vasopressin in the management of septic shock.
Russell JA
Crit Care; 2011 Aug; 15(4):226. PubMed ID: 21892977
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock.
Russell JA; Fjell C; Hsu JL; Lee T; Boyd J; Thair S; Singer J; Patterson AJ; Walley KR
Am J Respir Crit Care Med; 2013 Aug; 188(3):356-64. PubMed ID: 23796235
[TBL] [Abstract][Full Text] [Related]
18. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
Sacha GL; Lam SW; Wang L; Duggal A; Reddy AJ; Bauer SR
Crit Care Med; 2022 Apr; 50(4):614-623. PubMed ID: 34582425
[TBL] [Abstract][Full Text] [Related]
19. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
Bauer SR; Sacha GL; Reddy AJ
Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
[No Abstract] [Full Text] [Related]
20. Effects of continuous vasopressin infusion in patients with septic shock.
Obritsch MD; Jung R; Fish DN; MacLaren R
Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
